1.290CAD+0.78%Mkt Cap: 9.80M $P/E: —1d ago
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa recepto…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/B
Cheaper
1M Perf
Lower
$69.40BUSDP/E 25.2
$23.00BUSDP/E 20.0
$18.49BUSD
$16.95BUSDP/E 26.0
$15.35BUSDP/E 175.0
$15.16BUSDP/E 31.8
$12.29BUSD
$8.30BUSDP/E 21.1
$8.02BUSD
$7.22BUSDP/E 26.5
$7.09BUSDP/E 469.0
$5.52BUSDP/E 46.8
$3.54BUSDP/E 18.4
$3.48BUSDP/E 11.1
$3.22BUSDP/E 22.4
$2.66BUSDP/E 59.3
$2.70BUSD
$2.54BUSDP/E 17.6
$2.54BUSD
$2.24BUSDP/E 12.1
$1.92BUSDP/E 19.4
$2.00BUSD
$1.77BUSD
$1.88BUSDP/E 21.2
$1.90BUSD
$1.56BUSDP/E 18.4
$1.58BUSD
$1.37BUSDP/E 113.1
$1.27BUSDP/E 13.5
$1.13BUSDP/E 35.6
$1.17BUSDP/E 17.6
$1.23BUSD
$1.09BUSD
$1.07BUSDP/E Infinity
$964.80MUSD
$998.26MUSDP/E 195.2
$991.60MUSD
$912.76MUSDP/E 39.9
$895.85MUSDP/E 14.4
$889.80MUSDP/E 12.2
$814.31MUSDP/E Infinity
$693.02MUSDP/E 6.8
$704.28MUSDP/E 164.2
$522.76MUSDP/E 14.7
$521.87MUSD
$488.71MUSD
$457.03MUSD
$450.66MUSD
$432.38MUSD
$323.33MUSD
$317.55MUSDP/E 43.3
$312.68MUSD
$342.71MUSD
$305.81MUSD
$304.53MUSD
$288.10MUSDP/E 51.7
$308.25MUSDP/E 9.9
$294.94MUSDP/E 15.2
$268.98MUSDP/E 9.7
$250.67MUSDP/E 47.7
$261.08MUSDP/E 13.0
$239.98MUSDP/E 53.8
$196.92MUSD
$194.94MUSD
$194.66MUSD
$182.70MUSDP/E 8.8
$178.18MUSD
$147.49MUSDP/E 18.8
$151.86MUSD
$138.58MUSD
$148.14MUSD
$125.08MUSD
$119.66MUSDP/E 18.6
$100.44MUSD
$97.09MUSD
$85.39MUSDP/E 12.3
$80.64MUSD
$72.08MUSD
$66.94MUSDP/E 56.4
$67.12MUSD
$64.16MUSD
$66.36MUSDP/E 22.8
$55.72MUSD
$60.45MUSD
$48.97MUSD
$53.46MUSD
$50.41MUSD
$42.17MUSD
$43.54MUSD
$35.03MUSDP/E Infinity
$32.51MUSD
$29.51MUSD
$25.58MUSDP/E 221.0
$23.08MUSD
$23.13MUSD
$21.73MUSD
$21.66MUSD
$18.56MUSD
$16.34MUSD
$14.36MUSDP/E 17.5
$13.58MUSD
$12.11MUSD
$11.27MUSD
$11.45MUSD
$8.90MUSD
$7.07MUSDP/E 0.3
$6.32MUSD
$5.89MUSD
$4.95MUSDP/E 4.0
$5.64MUSDP/E Infinity
$3.29MUSDP/E 1.4
$2.15MUSD
$1.93MUSD
$1.90MUSDP/E 32.5
$1.54MUSD
$668.8KUSD
$216.1KUSDP/E 0.0
$350USD
Indicators:|
Key Statistics
Company
Market Cap9.80M $
Enterprise Value9.19M $
Revenue (TTM)22.81M $
Gross Profit8.56M $
Net Income (TTM)-5.17M $
Revenue/Share2.186 USD
Last Price1.290 CAD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees—
CountryCA
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINCA58469E4085
Valuation
P/E (Trailing)—
P/E (Forward)-4.16
PEG0.17
EV/EBITDA-2.58
EV/Revenue0.40
P/S0.43
P/B1.06
EPS (TTM)-0.65
EPS (Forward)-0.31
52W Range
0.850076% of range1.430
52W High1.430 CAD
52W Low0.8500 CAD
Profitability
Gross Margin40.71%
Oper. Margin-4.62%
EBITDA Margin-15.59%
Profit Margin-24.60%
ROE-54.98%
ROA-28.45%
Growth
Revenue Growth44.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-407.83K $
CapEx (TTM)—
FCF Margin-3.15%
FCF Yield-7.34%
Net Debt-538.18K $
Net Debt/EBITDA0.15
Balance Sheet
Debt/Equity0.07
Current Ratio1.04
Quick Ratio0.70
Book Value/Sh1.214 CAD
Cash/Share0.1480 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Splits
Last Split1:15
Split DateNov 2, 2012
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.10.44M
Float5.27M
Insiders27.30%
Institutions23.10%
Short Interest
Short Ratio1.4d
Short % Float0.03%
Short % Out.0.02%
Shares Short2.53K
Short (prev mo.)2.53K
Technical
SMA 501.136 (+13.6%)
SMA 2001.149 (+12.3%)
Beta1.06
S&P 52W Chg20.05%
Avg Vol (30d)2.43K
Avg Vol (10d)2.14K
Technical Indicators
RSI (14)64.0
MACD0.0344
MACD Signal0.0071
MACD Hist.+0.0273
BB Upper1.324 CAD
BB Middle1.134 CAD
BB Lower0.9436 CAD
BB Width33.59%
ATR (14)0.0412 CAD
Vol Ratio (20d)0.40x